Protalix BioTherapeutics (PLX) - Stock price history

Stock price history of Protalix BioTherapeutics from 1998 to 2026

Annual Stock Price Performance

Year	Performance
2026	21.67%
2025	-8.63%
2024	3.30%
2023	29.93%
2022	50.55%
2021	-76.82%
2020	1.97%
2019	-3.53%
2018	-55.07%
2017	57.14%
2016	-55.45%
2015	-45.45%
2014	-53.54%
2013	-27.96%
2012	3.80%
2011	-52.64%
2010	44.64%
2009	257.84%
2008	-46.82%
2007	-87.48%
2006	-58.87%
2005	2,025.00%
2004	-50.00%
2003	263.64%
2002	-52.17%
2001	22.67%
2000	-78.57%
1999	-53.33%
1998	-73.53%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Pfizer PFE	A$38.58	0.17%	🇺🇸 USA
Neurocrine Biosciences NBIX	A$188.28	1.19%	🇺🇸 USA
Amicus Therapeutics FOLD	A$20.58	0.07%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	A$43.63	4.65%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Protalix BioTherapeutics (PLX)